At Emendo, we help pharmaceutical companies with tailored strategic and operational support throughout every stage of the tech transfer process. We support transitions from development to commercial manufacturing, scale-ups, and site-to-site transfers of drug substance (DS), drug product (DP), packaging, and analytical methods. Our approach combines end-to-end project management, subject matter expertise, regulatory alignment, and structured process frameworks to ensure right-first-time execution.
We provide expert-led project management and subject matter expertise to drive technology transfers forward with speed and precision.
We design customized technology transfer frameworks to streamline activities and improve efficiency and scalability.
We embed regulatory planning into every stage of tech transfer, aligning submission strategies, quality documentation, and operational milestones to ensure audit readiness and a smooth path to commercial launch.
We assess, select, and oversee Contract Manufacturing Organizations while ensuring knowledge continuity across sending and receiving units, supporting smooth handovers and consistent execution.
At Emendo, our tech transfer services within pharmaceutical manufacturing provide end-to-end support across the full lifecycle of pharmaceutical technology transfers. We enable successful transfers of DS, DP, packaging, and analytical methods, using a proven framework that blends strategy, science, and execution.
We guide pharma and biotech companies through:
With our proactive, hands-on approach, we reduce transfer risk, protect product quality, and accelerate time to market – while ensuring compliance with WHO’s Technical Report Series 961 Annex 7 and alignment to ICH Q9 (Quality Risk Management).
We provide end-to-end support for pharmaceutical and biotech tech transfer projects, combining structured project management with deep scientific expertise.
From lifecycle planning and PPQ execution to regulatory strategy and CMO oversight, we ensure seamless collaboration between Sending and Receiving Units, regulatory alignment, and right-first-time transfer execution.
Our tailored frameworks, technical depth, and governance-driven approach secure compliant, efficient, and scientifically sound product transfers that enable successful launches and long-term operational excellence.
We lead the full lifecycle of tech transfer projects by combining structured project management with deep scientific expertise – ensuring robust governance, effective risk management, and right-first-time execution of PPQ and transfer activities. We boost collaboration between Sending Unit (SU) and Receiving Unit (RU) teams by embedding clear governance structures and practical tools to secure seamless knowledge flow and joint accountability.
Leading the full lifecycle of tech transfer projects by integrating classical project management disciplines with deep scientific expertise
Establishing governance setup, risk management, and stakeholder engagement grounded in technical understanding of product and process requirements, strengthening alignment and cooperation between SU and RU teams
Facilitating effective communication and knowledge continuity through standardized tools, templates, and meeting structures to support cross-site collaboration
Conducting root-cause analysis and issue resolution across development and commercial stages
Planning and execution of PPQ strategies including organizational and technical oversight, with joint involvement of SU and RU stakeholders
We provide deep subject matter expertise across DS, DP, and analytical methods, embedding Quality by Design (QbD) principles to promote product quality, and robust control strategies according to ICH Q8–Q11, with tailored transfer plans to ensure scientifically sound execution and regulatory alignment.
Applying SME knowledge in DS, DP, and analytical methods to ensure scientifically sound transfer execution
Facilitating QbD during transfers in collaboration with product and process SMEs
Defining comparability and control strategies that meet regulatory and quality standards
Designing and planning of stability studies to support transfer and registration timelines
Defining transfer and submission strategies tailored to product and market needs
We design and implement fit-for-purpose tech transfer frameworks and workflows customized to your organization, integrating QbD principles according to ICH Q8 and Q11 and stage-appropriate controls to create efficient, compliant, and scalable processes.
Designing and implementing streamlined tech transfer models and processes tailored to your organization
Integrating QbD principles and stage-appropriate controls into customized transfer workflows
We develop, plan, and align submission strategies with Regulatory Affairs, prepare supporting quality documentation, and ensure regulatory and operational readiness for successful product launch in line with ICH Q12 (Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management).
Developing and planning submission strategies in collaboration with Regulatory Affairs
Authoring and coordinating supporting quality documentation for regulatory submissions
Ensuring commercial launch readiness by aligning regulatory and operational requirements
We support the assessment, selection, and onboarding of CMOs, establish robust oversight structures, and manage relationships to ensure quality, compliance, and smooth execution throughout the transfer lifecycle.
Assessing, selecting, and onboarding CMOs based on technical and strategic fit
Establishing oversight structures, incl. person-in-plant roles, to ensure transfer quality and compliance
Managing relationships, fostering collaboration, and providing escalation support throughout the tech transfer lifecycle
Whether you’re scaling up for commercial launch, onboarding a new CMO, or transferring between sites, our Research & Development team ensures that your pharma tech transfer processes are streamlined, compliant, and globally aligned with regulatory standards and industry best practices.
Working closely with your internal teams and external partners, we safeguard knowledge continuity, support successful validation and PPQ, and deliver hands-on right-first-time execution across all technology transfer stages.
Our approach not only ensures right-first-time execution but also builds a foundation for long-term lifecycle management, giving our clients regulatory flexibility and efficient change control post-transfer. Our experience includes both DS and DP tech transfer, packaging tech transfer, and analytical method transfers – all supported by adherence to international guidance from ICH, WHO, EMA, FDA, and PDA.
CASE SPOTLIGHT
When a Danish biotech company faced a two-year-delayed drug product tech transfer, Emendo stepped in to restore momentum. The project had been marked by fragmented communication, staff turnover, and regulatory risks — jeopardizing both submission timelines and supply chain continuity.
Through structured governance, technology regulatory compliance, and expertise in pharmaceutical process validation, Emendo stabilized the project, onboarded a new CMO, and aligned all stakeholders under ICH Q9/Q10 standards. Within months, validation batches were successfully produced, knowledge continuity was secured, and the company achieved submission readiness.
Explore how we helped a MedTech client navigate the EU MDR transition by leading a science-driven material reformulation. The result: a fully compliant device that preserved critical product claims, improved performance, and reduced cost of goods – turning regulatory risk into competitive advantage.
Amid the COVID-19 pandemic, Emendo drove a rapid pharma tech transfer of a vaccine drug substance from Phase 2 to Phase 3 manufacturing for a BioTech client. The project was conducted under time pressure, global supply chain disruptions, and pharma regulatory compliance requirements.
Discover how we supported a client with a strategic competitive threat response when a competitor’s product launch posed a significant threat to their market position.
In collaboration with the client, Emendo developed a robust QbD template and toolkit that reduced QbD lead times by 80%, resulting in a 32-week reduction in time-to-market for technology transfer projects while enhancing consistency and embedding ICH Q8–Q12 regulatory expectations directly into the process.
Talk to an Expert in Tech Transfer
Curious about how we can support your next tech transfer? Connect with Pernille Bonnor to discuss how our tailored technology transfer services, frameworks, and expert support can accelerate your project and ensure a smooth, compliant handover from start to finish.
Pernille Bonnor
Scientific Senior Consultant
Technology transfer in pharma is a structured process of moving a product and its associated knowledge – incl. processes, documentation, and expertise – from one stage or site to another. Most often, this means scaling up from development to commercial manufacturing or transferring between manufacturing sites.
The key objectives of a successful tech transfer are to:
When executed well, tech transfer not only fulfills regulatory obligations but also protects product quality, reduces risk, and accelerates time-to-market.
